FIBROGEN INC
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included in signature pages)
POWER OFATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Thane Wettig and Juan Graham, jointly and severally, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Thane Wettig | Chief Executive Officer (Principal Executive Officer) | February 26, 2024 |
| Thane Wettig | ||
| /s/ Juan Graham | Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) | February 26, 2024 |
| Juan Graham | ||
| /s/ James A. Schoeneck | Chairman of the Board and Director | February 26, 2024 |
| James A. Schoeneck | ||
| /s/ Suzanne Blaug | Director | February 26, 2024 |
| Suzanne Blaug | ||
| /s/ Aoife Brennan | Director | February 26, 2024 |
| Aoife Brennan, M.B., B.Ch. | ||
| /s/ Benjamin F. Cravatt | Director | February 26, 2024 |
| Benjamin F. Cravatt, Ph.D. | ||
| /s/ Jeffrey L. Edwards | Director | February 26, 2024 |
| Jeffrey L. Edwards | ||
| /s/ Jeffrey W. Henderson | Director | February 26, 2024 |
| Jeffrey W. Henderson | ||
| /s/ Maykin Ho | Director | February 26, 2024 |
| Maykin Ho, Ph.D. | ||
| /s/ Gerald Lema | Director | February 26, 2024 |
| Gerald Lema | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.